Search
-
Women We Admire: Embracing Equity for Better Outcomes
Women We Admire is a membership organization comprised of the most accomplished women executives and leaders across the U.S. and Canada.
-
ESG – a time for leadership, focus and communication, but above all action
Concluding from the latest Ipsos ESG Council report, it's increasingly clear ESG's role as an agent for positive change.
-
Despite Softening Inflation, Canadians’ Affordability Concerns Remain Acute
Eight in ten (81%) continue to be concerned about rising everyday costs, while seven in ten (71%) are concerned that interest rates are rising faster than they can adjust.
-
Do and don’ts for understanding generations
The more we look at generations the less we know about them. That's why it is important to see the trees in the data forest.
-
Ipsos wins fifth consecutive MSPA Americas Shoppers’ Choice Award
Ipsos has been recognized by the MSPA Americas Shoppers’ Choice Awards for the fifth year in a row, affirming Ipsos’ reputation as a best-in-class provider within the highly competitive mystery shopping space.
-
AI is making the world more nervous
One in three workers expect AI to lead to the loss of their current job.
-
DEI Data Summit
Join Ipsos’ Grace Tong to hear more about measuring pay equity to take action on structural and implicit bias inside an organization.
-
Ipsos launches Non-Interventional Studies (NIS) Centre of Expertise
The new NIS Centre of Expertise, part of Ipsos’ global healthcare business, consolidates Ipsos’ extensive capabilities in real world evidence, an area of increasing priority for healthcare companies.
-
Logjam in Federal Vote Support Breaks to Advantage of Conservatives
Tory Support Growing (37%, +4 pts) at the Expense of Liberals (32%, -1 pt) and NDP (16%, - 2pts)
-
Oncology: the disease, dynamics & challenges of market research
The oncology treatment landscape rarely stands still, and its constant evolution affects all those involved – from patients and their carers to cancer treaters to the companies who manufacture and market treatments.